C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,607,935 | -19.8% | 864,481 | +18.6% | 0.01% | -16.7% |
| Q2 2023 | $2,004,588 | -11.8% | 728,941 | +0.7% | 0.01% | -14.3% |
| Q1 2023 | $2,272,421 | -47.1% | 723,701 | -0.7% | 0.01% | -51.7% |
| Q4 2022 | $4,299,159 | -33.7% | 728,671 | -1.4% | 0.03% | -43.1% |
| Q3 2022 | $6,481,000 | +61.5% | 738,993 | +38.8% | 0.05% | +64.5% |
| Q2 2022 | $4,014,000 | +353.0% | 532,420 | +2174.0% | 0.03% | +416.7% |
| Q2 2021 | $886,000 | – | 23,413 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |